Henry Schein (NASDAQ:HSIC) Coverage Initiated by Analysts at Wells Fargo & Company

Wells Fargo & Company initiated coverage on shares of Henry Schein (NASDAQ:HSIC - Free Report) in a research report released on Friday morning, Marketbeat Ratings reports. The firm issued an equal weight rating and a $80.00 target price on the stock.

A number of other analysts have also commented on the stock. Jefferies Financial Group boosted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Barrington Research increased their price objective on Henry Schein from $82.00 to $90.00 and gave the stock an "outperform" rating in a research note on Thursday, January 30th. StockNews.com upgraded Henry Schein from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Mizuho initiated coverage on Henry Schein in a report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target for the company. Finally, Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and raised their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Eight investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein has an average rating of "Moderate Buy" and a consensus target price of $80.09.

Henry Schein Stock Up 2.1 %

Henry Schein stock traded up $1.63 during midday trading on Friday, reaching $77.63. The stock had a trading volume of 2,573,709 shares, compared to its average volume of 1,480,900. The company has a fifty day moving average price of $74.03 and a two-hundred day moving average price of $72.02. Henry Schein has a 12 month low of $63.67 and a 12 month high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $9.68 billion, a P/E ratio of 31.95, a PEG ratio of 2.21 and a beta of 0.91.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HSIC. Clarkston Capital Partners LLC raised its holdings in shares of Henry Schein by 5.4% in the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company's stock worth $101,900,000 after purchasing an additional 71,560 shares during the period. Nuance Investments LLC raised its stake in shares of Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock valued at $166,072,000 after buying an additional 414,748 shares during the period. Olstein Capital Management L.P. raised its stake in shares of Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after buying an additional 16,000 shares during the period. B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Henry Schein during the 3rd quarter valued at $515,000. Finally, Equitable Trust Co. bought a new position in shares of Henry Schein during the 4th quarter worth $417,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.